Canton-based Personal Genome Diagnostics closed on $75 million in Series B funding and plans to triple its square footage with a new office.
SUBSCRIBE
Biohealth Innovation
Founding Member of
Biohealth Innovation
Canton-based Personal Genome Diagnostics closed on $75 million in Series B funding and plans to triple its square footage with a new office.